MO

Merouane Ounadjela

Life Sciences Consulting at DeciBio

San Francisco, California

Overview 

Merouane Ounadjela is a seasoned professional in the life sciences business, currently serving as a Senior Analyst at Northpond Ventures in San Francisco, California. With a background in molecular biology, genetics, and biotechnology, Merouane has excelled in roles involving due diligence, portfolio management, and venture capital, making significant contributions to companies like DeciBio and Intellia Therapeutics. Highlights of Merouane's career include co-founding the NYC branch of Nucleate and serving as an Associate Researcher at the Icahn School of Medicine at Mount Sinai, showcasing a diverse range of experience in life sciences consulting and research across various organizations.

Work Experience 

D

DeciBio

  • Life Sciences Consulting

    2024 - Current

NV

Northpond Ventures

  • Senior Analyst

    2021 - 2024

Northpond Ventures is a private equity and venture capital that focuses on science-driven projects in life sciences and technology.

npv.vc
N

Nucleate

  • Co-Founder of NYC Branch

    2020 - 2022

    Co-founder of Nucleate NYC, the NYC branch of a biotechnology entrepreneurship program built to empower the next generation of life science entrepreneurs.

a collaborative venture program enabling the formation of biotechnology companies addressing climate & sustainability challenges

nucleate.xyz
X

Xontogeny

  • Summer Intern

    2021 - 2021

Xontogeny is a biotech aggregator that seeks to accelerate the development of life science technologies.

Raised $15,000,000.00 from Perceptive Advisors.

xontogeny.com
RI

RTW Investments, LP

  • Project Intern

    2021 - 2021

RTW Investments makes investments in forward-thinking healthcare companies.

rtwfunds.com
JC

JPMorgan Chase & Co.

  • Life Science Tools and Diagnostics Equity Research Intern

    2020 - 2021

Morgan Health is the healthcare investment arm of JPMorgan Chase.

jpmorganchase.com
AV

Alix Ventures

  • VC Ambassador

    2020 - 2021

Alix Ventures: Driving Patient Impact - Supporting Early Stage Startups Engineering Biology to Drive Radical Advances in Human Health

alix.vc
IS

Icahn School of Medicine at Mount Sinai

  • Associate Researcher

    2019 - 2020

IT

Intellia Therapeutics, Inc.

  • Research Associate, Analytical Development

    2018 - 2019

C

Cytokinetics

  • Intern, Discovery Biology

    2017 - 2017

    Developed expression and purification strategies for a novel multi-subunit target protein.

Cytokinetics is a biopharmaceutical company developing therapies for debilitating diseases.

Raised $1,760,450,000.00 from Royalty Pharma, Deerfield, Federated Kaufmann Fund and Red Abbey Venture Partners.

cytokinetics.com

Education 

Articles About Merouane

Relevant Websites